Free Republic

ORLANDO, Fla. (AP) — A plan by Florida health officials that likely would restrict Medicaid insurance coverage for gender dysphoria treatments for transgender people lacks sound medical justification and may be politically motivated, according to a group of academics from Yale University and other schools. The Florida Agency for Health Care Administration said puberty blockers, cross-sex hormones and sex reassignment surgery have not been proven safe or effective in treating gender dysphoria. But a group of seven scientists and a law professor from Yale and other schools said in a report last week that the Florida’s agency’s conclusions are “incorrect...